After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Digital health applications and therapeutics have exploded over the last 10 years. With over 350,000 health and wellness apps ...

There are tons of different wireless earbuds on offer at a whole range of price points, but the JBL Live Beam 3 earbuds are a ...

Hobart Devco, LLC. has proposed the construction of a six-building complex on a 168-acre parcel roughly half a mile from the ...

Kim Kelderman; Chief Executive Officer, Chief Operating Officer, Director; Bio-Techne Corp James Hippel; Chief Financial Officer, Executive Vice President - Finance; Bio-Techne Corp Good morning, and ...

As for visitors Cardiff, Ryotaro Tsunoda (knock), David Turnbull (muscle), Isaak Davies (leg) and Roko Simic (knock) remain ...

Greg Ott, the owner of Ott Insurance Group, owns two buildings near the intersection of Cottman Avenue and Leonard Street ...